Avita Medical share price today

(RCEL)

Avita Medical share price is $12.91 & ₹1,099.91 as on 25 Dec 2024, 2.30 'hrs' IST

$12.91

▲

1.16

(9.87%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Avita Medical share price in Dollar and Rupees. Guide to invest in Avita Medical from India. Also see the sentimental analysis on Indian investors investing in Avita Medical. Get details on the Indian mutual funds that are investing in Avita Medical. Get Analyst recommendations and forecasts along with all the Avita Medical's financials.

Avita Medical share price movements

Today's Low: $12.11
Today's High: $13.37
$12.91
6.2%
Downside
Day's Volatility :9.39%
Upside
3.4%
52 Weeks Low: $7.51
52 Weeks High: $18.93
$12.91
41.83%
Downside
52 Weeks Volatility :60.33%
Upside
31.8%

Avita Medical Returns

Period	Avita Medical Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	22.02%	-9.0%	0.0%
6 Months	62.39%	-4.6%	0.0%
1 Year	-11.39%	3.0%	0.0%
3 Years	5.22%	0.0%	-21.1%

Avita Medical Key Statistics

in dollars & INR

Previous Close	$11.75
Open	$12.93
Today's High	$13.365
Today's Low	$12.11
Market Capitalization	$338.5M
Today's Volume	$175.6K
52 Week High	$18.93
52 Week Low	$7.51
Revenue TTM	$60.0M
EBITDA	$-57.9M
Earnings Per Share (EPS)	$-2.23
Profit Margin	-95.47%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-152.44%

How to invest in Avita Medical from India?

It is very easy for Indian residents to invest directly in Avita Medical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avita Medical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Avita Medical or RCEL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avita Medical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avita Medical shares which would translate to 0.066 fractional shares of Avita Medical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Avita Medical, in just a few clicks!

Returns in Avita Medical for Indian investors in Rupees

Investment Value

₹1,00,000

Avita Medical investment value today

Current value as on today

₹90,845

Returns

₹9,155

(-9.15%)

Returns from Avita Medical Stock

₹11,393 (-11.39%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Avita Medical

-32%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Avita Medical on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -32% less investors are searching Avita Medical in the last 30 days versus the previous period.

Global Institutional Holdings in Avita Medical

BlackRock Inc
6.80%
Vanguard Group Inc
5.41%
Geode Capital Management, LLC
2.27%
State Street Corp
1.98%
Essex Investment Management Company, LLC
0.88%
Northern Trust Corp
0.83%

Analyst Recommendation on Avita Medical

Buy

78%Buy

21%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Avita Medical(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Avita Medical

What analysts predicted

Upside of 43.01%

Current:

$12.91

Target:

$18.46

Insights on Avita Medical

Price Movement
In the last 7 days, RCEL stock has moved up by 12.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 11.10M → 19.54M (in $), with an average increase of 24.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -15.39M → -16.20M (in $), with an average decrease of 5.3% per quarter
RCEL vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 62.7% return, outperforming this stock by 68.2%
RCEL vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 113.2% return, outperforming this stock by 110.5%
Price to Sales
ForRCEL every $1 of sales, investors are willing to pay $5.5, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Avita Medical Financials in INR & Dollars

	FY21	Y/Y Change
Revenue	$10.2M	↑ 0.0%
Net Income	$-30.1M	↑ 0.0%
Net Profit Margin	-294.68%	↑ 0.0%

	FY21	Y/Y Change
Revenue	$10.2M	↑ 0.0%
Net Income	$-30.1M	↑ 0.0%
Net Profit Margin	-294.68%	↑ 0.0%

	FY22	Y/Y Change
Revenue	$34.1M	-
Net Income	$-26.4M	-
Net Profit Margin	-77.47%	-

	FY23	Y/Y Change
Revenue	$33.6M	↓ 0.83%
Net Income	$-23.7M	↓ 9.67%
Net Profit Margin	-70.56%	↑ 6.91%

	FY23	Y/Y Change
Revenue	$33.6M	↓ 0.83%
Net Income	$-23.7M	↓ 9.67%
Net Profit Margin	-70.56%	↑ 6.91%

	Q2 FY23	Q/Q Change
Revenue	$11.9M	↑ 67.26%
Net Income	$-10.5M	↑ 13.05%
Net Profit Margin	-88.35%	↑ 42.37%

	Q3 FY23	Q/Q Change
Revenue	$13.6M	↑ 20.29%
Net Income	$-8.7M	↓ 13.07%
Net Profit Margin	-63.85%	↑ 24.5%

	Q4 FY23	Q/Q Change
Revenue	$9.5M	↓ 33.12%
Net Income	$-4.7M	↓ 47.87%
Net Profit Margin	-49.77%	↑ 14.08%

	Q1 FY24	Q/Q Change
Revenue	$7.3M	↓ 21.78%
Net Income	$-12.2M	↑ 164.09%
Net Profit Margin	-168.03%	↓ 118.26%

	Q2 FY24	Q/Q Change
Revenue	$10.1M	↑ 36.84%
Net Income	$-10.2M	↓ 17.5%
Net Profit Margin	-101.3%	↑ 66.73%

	Q3 FY24	Q/Q Change
Revenue	$19.5M	↑ 28.63%
Net Income	$-16.2M	↑ 5.28%
Net Profit Margin	-82.91%	↑ 18.39%

	FY21	Y/Y Change
Profit	$8.1M	-

	FY22	Y/Y Change
Profit	$28.1M	-

	FY23	Y/Y Change
Profit	$28.3M	-

	Q2 FY23	Q/Q Change
Profit	$9.6M	↑ 7.9%

	Q3 FY23	Q/Q Change
Profit	$11.5M	↑ 25.13%

	Q4 FY23	Q/Q Change
Profit	$8.3M	↓ 30.88%

	Q1 FY24	Q/Q Change
Profit	$6.3M	↓ 22.65%

	Q2 FY24	Q/Q Change
Profit	$8.7M	↑ 36.42%

	Q3 FY24	Q/Q Change
Profit	$16.4M	↑ 25.01%

	FY21	Y/Y Change
Operating Cash Flow	$-16.3M	↑ 0.0%
Investing Cash Flow	$-839.8K	↑ 0.0%
Financing Cash Flow	$55.1M	↑ 0.0%

	FY21	Y/Y Change
Operating Cash Flow	$-16.3M	↑ 0.0%
Investing Cash Flow	$-839.8K	↑ 0.0%
Financing Cash Flow	$55.1M	↑ 0.0%

	FY22	Y/Y Change
Operating Cash Flow	$-18.9M	↑ 55.47%
Investing Cash Flow	$-13.0M	↓ 61.5%
Financing Cash Flow	$892.3K	↓ 97.94%

	FY22	Y/Y Change
Operating Cash Flow	$-18.9M	↑ 55.47%
Investing Cash Flow	$-13.0M	↓ 61.5%
Financing Cash Flow	$892.3K	↓ 97.94%

	FY23	Y/Y Change
Operating Cash Flow	$-18.8M	↑ 0.0%
Investing Cash Flow	$-13.0M	↑ 0.0%
Financing Cash Flow	$888.1K	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-9.2M	↑ 0.68%
Investing Cash Flow	$12.3M	↑ 0.0%
Financing Cash Flow	$172.5K	↑ 0.37%

Avita Medical Technicals Summary

Sell

Neutral

Buy

Avita Medical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Avita Medical Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Avita Medical Inc	0.16%	62.39%	-11.39%	5.22%	-71.87%
Stryker Corporation	-4.86%	8.88%	24.0%	37.11%	77.64%
Boston Scientific Corp.	0.95%	18.27%	62.57%	111.2%	102.42%
Edwards Lifesciences Corp.	5.35%	-19.24%	-1.09%	-42.27%	-2.7%
Abbott Laboratories	-2.71%	9.66%	4.53%	-18.87%	32.21%
Medtronic Plc	-4.83%	2.79%	-1.07%	-21.92%	-27.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Avita Medical Inc	NA	NA	NA	-3.35	-1.52	-0.45	NA	0.47
Stryker Corporation	39.7	39.7	2.56	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	75.26	75.26	1.65	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	29.1	29.1	6.92	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.88	34.88	2.22	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.94	24.94	1.49	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Avita Medical Inc	Buy	$338.5M	-71.87%	NA	-95.47%
Stryker Corporation	Buy	$141.3B	77.64%	39.7	16.34%
Boston Scientific Corp.	Buy	$134.2B	102.42%	75.26	11.26%
Edwards Lifesciences Corp.	Buy	$44.5B	-2.7%	29.1	65.86%
Abbott Laboratories	Buy	$199.0B	32.21%	34.88	13.99%
Medtronic Plc	Buy	$104.6B	-27.8%	24.94	12.06%

About Avita Medical

avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.

Organization	Avita Medical
Employees	207
CEO	Mr. James M. Corbett
Industry	Health Technology

Management People of Avita Medical

Name	Title
Mr. James M. Corbett	CEO, President & Executive Director
Mr. David O'Toole	Chief Financial Officer
Mr. David Fencil	Senior Vice President of Global Operations
Dr. Katie Bush Ph.D.	Senior Vice President of Scientific & Medical Affairs
Ms. Jessica Ekeberg	Investor Relations Executive
Ms. Nicole Linda Kelsey	Chief Legal & Compliance Officer and Corporate Secretary
Ms. Debbie Garner	Senior Vice President of Global Marketing & Strategy
Mr. Rob Hall	Senior Vice President of Human Resources
Dr. Niraj Doshi J.D., P.M.P., Ph.D.	Senior Vice President of Product Development & Program Management
Mr. Ron Lagerquist	Senior Vice President of Quality Assurance & Regulatory Affairs

Important FAQs about investing in Avita Medical from India :

What is Avita Medical share price today?

Avita Medical share price today stands at $12.91, Open: $12.93 ; Previous Close: $11.75 ; High: $13.37 ; Low: $12.11 ; 52 Week High: $18.93 ; 52 Week Low: $7.51. The stock opens at $12.93, after a previous close of $11.75. The stock reached a daily high of $13.37 and a low of $12.11, with a 52-week high of $18.93 and a 52-week low of $7.51.

Can Indians buy Avita Medical shares?

Yes, Indians can invest in the Avita Medical (RCEL) from India.

With INDmoney, you can buy Avita Medical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Avita Medical at zero transaction cost.

How can I buy Avita Medical shares from India?

It is very easy to buy Avita Medical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avita Medical be purchased?

Yes, you can buy fractional shares of Avita Medical with INDmoney app.

What are the documents required to start investing in Avita Medical stocks?

To start investing in Avita Medical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.